Vanguard Group’s CAS Medical Systems, Inc. CASM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-830,269
| Closed | -$2.02M | – | 4220 |
|
|
2019
Q1 | $2.02M | Buy |
830,269
+239,222
| +40% | +$514K | ﹤0.01% | 3446 |
|
|
2018
Q4 | $945K | Buy |
591,047
+43,487
| +8% | +$81K | ﹤0.01% | 3580 |
|
|
2018
Q3 | $1.25M | Buy |
547,560
+15,155
| +3% | +$32.3K | ﹤0.01% | 3666 |
|
|
2018
Q2 | $1.04M | Buy |
532,405
+40
| +0% | +$60 | ﹤0.01% | 3676 |
|
|
2018
Q1 | $671K | Buy |
532,365
+484
| +0.1% | +$546 | ﹤0.01% | 3730 |
|
|
2017
Q4 | $409K | Hold |
531,881
| – | – | ﹤0.01% | 3793 |
|
|
2017
Q3 | $489K | Buy |
531,881
+17,749
| +3% | +$18.2K | ﹤0.01% | 3754 |
|
|
2017
Q2 | $591K | Hold |
514,132
| – | – | ﹤0.01% | 3695 |
|
|
2017
Q1 | $746K | Hold |
514,132
| – | – | ﹤0.01% | 3657 |
|
|
2016
Q4 | $828K | Buy |
514,132
+6,400
| +1% | +$10.8K | ﹤0.01% | 3616 |
|
|
2016
Q3 | $868K | Hold |
507,732
| – | – | ﹤0.01% | 3617 |
|
|
2016
Q2 | $934K | Buy |
507,732
+15,532
| +3% | +$29.1K | ﹤0.01% | 3622 |
|
|
2016
Q1 | $699K | Hold |
492,200
| – | – | ﹤0.01% | 3698 |
|
|
2015
Q4 | $871K | Buy |
492,200
+2,800
| +0.6% | +$3.95K | ﹤0.01% | 3667 |
|
|
2015
Q3 | $611K | Hold |
489,400
| – | – | ﹤0.01% | 3791 |
|
|
2015
Q2 | $627K | Buy |
489,400
+6,800
| +1% | +$8.83K | ﹤0.01% | 3802 |
|
|
2015
Q1 | $644K | Buy |
482,600
+247,234
| +105% | +$356K | ﹤0.01% | 3757 |
|
|
2014
Q4 | $388K | Buy |
235,366
+3,200
| +1% | +$5.66K | ﹤0.01% | 3797 |
|
|
2014
Q3 | $450K | Buy |
232,166
+100
| +0% | +$172 | ﹤0.01% | 3742 |
|
|
2014
Q2 | $466K | Buy |
232,066
+25,431
| +12% | +$53.9K | ﹤0.01% | 3705 |
|
|
2014
Q1 | $448K | Buy |
206,635
+41,468
| +25% | +$88.1K | ﹤0.01% | 3676 |
|
|
2013
Q4 | $281K | Buy |
165,167
+54,211
| +49% | +$84.6K | ﹤0.01% | 3717 |
|
|
2013
Q3 | $150K | Buy |
110,956
+43,040
| +63% | +$63.2K | ﹤0.01% | 3737 |
|
|
2013
Q2 | $112K | Buy |
+67,916
| New | +$126K | ﹤0.01% | 3720 |
|
Vanguard Group's CASM Position: Q2 2019 in Review
Vanguard Group sold out of CAS Medical Systems, Inc. (CASM) in Q2 2019, closing a stake of 830,269 shares — an estimated $2.02M sold.
Vanguard Group first reported a position in CASM in Q2 2013 and held it in 24 quarters. The position peaked at $2.02M in Q1 2019. 0 funds tracked by Wall St. Rank hold CASM as of Q2 2019.
- Vanguard Group reported no remaining CAS Medical Systems, Inc. position as of Q2 2019 after selling out during the quarter.
- Vanguard Group sold 830,269 CAS Medical Systems, Inc. shares in Q2 2019, an estimated $2.02M.
- Vanguard Group first reported a position in CAS Medical Systems, Inc. in Q2 2013 and held it in 24 quarters.
- Vanguard Group's CAS Medical Systems, Inc. position peaked at $2.02M in Q1 2019.
- 0 funds tracked by Wall St. Rank held CAS Medical Systems, Inc. as of Q2 2019.
Based on Vanguard Group's 13F filing for Q2 2019, filed 14 Aug 2019.